Provention Bio, Inc.
Provention Bio, Inc. (PRVB) Stock Overview
Explore Provention Bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.4B
P/E Ratio
-16.44
EPS (TTM)
$-1.52
ROE
1.33%
PRVB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Provention Bio, Inc. (PRVB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $41.68.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.44 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.